Stocks Teva Pharmaceutical Industries Ltd

More

  • The Dow jumped 150 points off the morning lows. Does this bullish reversal mean you should jump back in?

  • Fortune

    For the first time, Fortune opened its 100 Fastest-Growing Companies list to businesses around the world (if they trade on a U.S. exchange and file quarterly reports)—a change that landed Canada's Research in Motion in the No. 1 spot and two Chinese companies in the top 10.

  • For the first time, Fortune opened its 100 Fastest-Growing Companies list to businesses around the world (if they trade on a U.S. exchange and file quarterly reports)—a change that landed Canada's Research in Motion in the No. 1 spot and two Chinese companies in the top 10.

  • The bulls just can't drive the market beyond its 9-month high. Is a correction coming?

  • Stocks ended slightly lower Tuesday, though the Nasdaq eked out a gain. And Citigroup shares soared.

  • Stocks skidded Tuesday after a report showed consumer confidence is waning amid worries about the job market. It was a struggle all morning as investors juggled another batch of disappointing earnings results against an encouraging report on the housing market.

  • After a huge two week really, is Tuesday's market weakness an early sign of a sharp pull back or nothing more than expected profit taking?

  • So far this quarter, only one S&P healthcare company, Aetna, has missed its consensus EPS estimate.  This week there are over 20 more healthcare companies reporting.  Yesterday after the bell Amgen blew the cover off the ball with a 40% rise in earnings and this morning, Teva Pharmaceuticals beat by three cents per share.

  • Stock futures drifted slightly lower ahead of the open Tuesday as investors waited for the next batch of earnings and key economic data.

  • Cramer makes the call on viewers' favorite stocks.

  • Many companies have reported earnings that have surprised to the upside, but how will they perform for the rest of the year? Dan Genter, CEO of RNC Genter Capital Management shared his insight and investment strategy.

  • With UnitedHealthcare due to report earnings on Tuesday, Wall Street is taking close notice of late developments in the area of healthcare reform.

  • Michael Jackson

    The Food and Drug Administration today announced that Teva Pharmaceutical Industries is voluntarily recalling two lots of the anesthetic Propofol because there are higher levels of potentially fatal endotoxins...Propofol is the same drug that was reportedly found in Michael Jackson’s house.

  • Bugs Bunny

    Could a carrot-chomping Bugs Bunny become a drug pitchman? Well, maybe, if the small Israeli company Protalix BioTherapeutics could pay Warner Brothers enough money for Bugs' services.

  • A New York Stock Exchange trader.

    The Fed's decision to keep interest rates low because of the weak economy caused a stock rally to fade and heightened concerns that Fed Chairman Bernanke's "green shoots" were turning brown.

  • piggy_bank.jpg

    "Slow growth and higher taxes—that's not a recipe for higher stocks," says one economist. "The threat of deflationary spiral...that's what spooked the market."

  • graphic_word_ofthe_street.jpg

    The Dow and S&P 500 gained on Thursday as data on the job market and regional manufacturing revived hopes that the economy may be stabilizing.

  • graphic_fast_money.jpg

    As healthcare lands squarely in Washington’s sights, how should you play the sector?

  • Jon Najarian, co-founder of Optionmonster.com breaks down the M&A with Scott Wapner on Tuesday’s Fast Money Final Call.

  • CNBC’s Mike Huckman is keeping a close eye on Big Pharma earnings. And he suggests you do the same - because he's spotted a devil the details.